Literature DB >> 9788663

Dexamethasone stimulates proteasome- and calcium-dependent proteolysis in cultured L6 myotubes.

L Wang1, G J Luo, J J Wang, P O Hasselgren.   

Abstract

The effect of dexamethasone on protein degradation and the involvement of different proteolytic pathways were examined in cultured L6 myotubes. Treatment of the cells with dexamethasone resulted in an approximately 20% increase in protein degradation at a hormone concentration of 10(-7) to 10(-6) M. By using various proteolytic blockers, evidence was found that the dexamethasone-induced increase in protein breakdown mainly reflected energy-proteasome-dependent proteolysis and to a lesser extent calcium-dependent protein breakdown. In contrast, the hormone treatment did not increase lysosomal proteolysis. mRNA levels for cathepsin B, ubiquitin, and the proteasome subunit C3 were increased by dexamethasone. The results suggest that glucocorticoids stimulate calcium and energy-proteasome-dependent muscle proteolysis and that changes in mRNA levels for proteolytic enzymes do not necessarily reflect the involvement of different proteolytic pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788663     DOI: 10.1097/00024382-199810000-00011

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  31 in total

1.  Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle.

Authors:  Michael J Menconi; Zoltan P Arany; Nima Alamdari; Zaira Aversa; Patricia Gonnella; Patrick O'Neal; Ira J Smith; Steven Tizio; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-20       Impact factor: 4.310

2.  Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism.

Authors:  Liping Sun; Julie S Trausch-Azar; Louis J Muglia; Alan L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

3.  Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders.

Authors:  S Krause; U Kuckelkorn; T Dörner; G-R Burmester; E Feist; P-M Kloetzel
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

4.  In utero glucocorticoid exposure reduces fetal skeletal muscle mass in rats independent of effects on maternal nutrition.

Authors:  Ganga Gokulakrishnan; Irma J Estrada; Horacio A Sosa; Marta L Fiorotto
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-14       Impact factor: 3.619

5.  Progress in burns research: a review of advances in burn pathophysiology.

Authors:  P I Jewo; I O Fadeyibi
Journal:  Ann Burns Fire Disasters       Date:  2015-06-30

6.  β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy.

Authors:  Zaira Aversa; Nima Alamdari; Estibaliz Castillero; Maurizio Muscaritoli; Filippo Rossi Fanelli; Per-Olof Hasselgren
Journal:  Biochem Biophys Res Commun       Date:  2012-06-13       Impact factor: 3.575

7.  Human tau may modify glucocorticoids-mediated regulation of cAMP-dependent kinase and phosphorylated cAMP response element binding protein.

Authors:  Yudong Liu; Ying Su; Shenggang Sun; Tao Wang; Xian Qiao; Hui Li; Xiaoqin Run; Zhihou Liang
Journal:  Neurochem Res       Date:  2012-05       Impact factor: 3.996

8.  The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.

Authors:  Marc G Jeschke; Celeste C Finnerty; Oscar E Suman; Gabriela Kulp; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

9.  Dexamethasone-induced selenoprotein S degradation is required for adipogenesis.

Authors:  Choon Young Kim; Kee-Hong Kim
Journal:  J Lipid Res       Date:  2013-05-18       Impact factor: 5.922

10.  Pathophysiologic response to severe burn injury.

Authors:  Marc G Jeschke; David L Chinkes; Celeste C Finnerty; Gabriela Kulp; Oscar E Suman; William B Norbury; Ludwik K Branski; Gerd G Gauglitz; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.